Bruce N. Jacobs - 17 Oct 2022 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Financial Officer
Signature: /s/ Bruce N. Jacobs
Issuer symbol: KYMR
Transactions as of: 17 Oct 2022
Net transactions value: +$20,800
Form type: 4
Filing time: 17 Oct 2022, 20:12:54 UTC
Previous filing: 03 May 2022
Next filing: 24 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$20,800	+10,000	+16%	$2.08^*	71,279	17 Oct 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-6.3%	$0.000000	149,899	17 Oct 2022	Common Stock	10,000	$2.08	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number includes 465 shares acquired under the Registrant's employee stock purchase plan on May 31, 2022.
F2	Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.